UNSPSC 51161534: Denbufylline

This classification denotes a phosphodiesterase inhibitor with the molecular formula C16H24N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 04B949KO6F, chemically known as 3,7-dihydro-1,3-dibutyl-7-(2-oxopropyl)-1h-purine-2,6-dione but generally known as denbufylline, which bears US NIH Compound Identifier 2984. European Medicines Agency schedules Denbufylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06974MIG. The term DENBUFYLLINE is an International Non-Proprietary Name.

UNSPSC 51161534 Denbufylline is a Commodity code covering a pharmaceutical active ingredient used in respiratory and circulatory medications. State and local governments procure denbufylline primarily through their health and human services agencies, corrections departments, and public health systems for inclusion in formularies and medication supplies distributed to patients in state facilities, correctional institutions, and public clinics. The code reflects pharmaceutical procurement at the active-ingredient level rather than finished-dosage-form procurement, and is typically embedded in larger pharmaceutical supply contracts or formulary management agreements rather than solicited as a standalone line item.

The source provides no recent state and local contract opportunities under this code. Without posted RFP, RFQ, IFB, or ITB records, current market activity under UNSPSC 51161534 cannot be characterized by issuing-body type, geographic concentration, or recent solicitation patterns.